Drug-induced lupus erythematosus (Q44377): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
O lúpus eritematoso induzido por drogas é uma síndrome na qual anticorpos anti-nucleares positivos estão associados a sintomas, como febre, mal-estar, artrite, artralgia/mialgia intensa, serosite e/ou erupção cutânea. A síndrome aparece durante a terapia com alguns medicamentos (p.ex., procainamida, hidralazina, fenitoína) e inibidores do fator de necrose tumoral. Ocorre predominantemente em caucasianos, tem menos predileção pelo sexo feminino do que o lúpus eritematoso sistêmico, raramente envolve rins ou cérebro, raramente está associado ao anti-dsDNA, é comumente associado a anticorpos anti-histonas e, geralmente, se resolve em várias semanas após a descontinuação do medicamento agressor. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Drug-induced lupus erythematosus is a syndrome in which positive antinuclear antibodies are associated with symptoms, such as fever, malaise, arthritis, intense arthralgia/myalgia, serositis, and/or rash. The syndrome appears during therapy with certain medications (e.g., procainamide, hydralazine, phenytoin) and tumour necrosis factor inhibitors. It occurs predominantly in Caucasians, has less female predilection than SLE, rarely involves kidneys or brain, is rarely associated with anti-dsDNA, is commonly associated with antibodies to histones, and usually resolves over several weeks after discontinuation of the offending medication. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1239818910 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:4A40.1 | |||||||||||||||
| Property / CURIE: CID11:4A40.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-4A40.1 | |||||||||||||||
| Property / Canary Token: dki-india-4A40.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: M32.0 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:49, 13 August 2026
Drug-induced lupus erythematosus is a syndrome in which positive antinuclear antibodies are associated with symptoms, such as fever, malaise, arthritis, intense arthralgia/myalgia, serositis, and/or rash. The syndrome appears during therapy with certain medications (e.g., procainamide, hydralazine, phenytoin) and tumour necrosis factor inhibitors. It occurs predominantly in Caucasians, has less female predilection than SLE, rarely involves kidneys or brain, is rarely associated with anti-dsDNA, is commonly associated with antibodies to histones, and usually resolves over several weeks after discontinuation of the offending medication.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 4A40.1 |
||
| English | Drug-induced lupus erythematosus |
Drug-induced lupus erythematosus is a syndrome in which positive antinuclear antibodies are associated with symptoms, such as fever, malaise, arthritis, intense arthralgia/myalgia, serositis, and/or rash. The syndrome appears during therapy with certain medications (e.g., procainamide, hydralazine, phenytoin) and tumour necrosis factor inhibitors. It occurs predominantly in Caucasians, has less female predilection than SLE, rarely involves kidneys or brain, is rarely associated with anti-dsDNA, is commonly associated with antibodies to histones, and usually resolves over several weeks after discontinuation of the offending medication. |
Statements
CID11:4A40.1
0 references
dki-india-4A40.1
0 references
Concluído
0 references
13 August 2026
0 references
